ADC Therapeutics (ADCT) Inventory (2021 - 2023)
Historic Inventory for ADC Therapeutics (ADCT) over the last 3 years, with Q3 2023 value amounting to $22.7 million.
- ADC Therapeutics' Inventory rose 4435.06% to $22.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $22.7 million, marking a year-over-year increase of 4435.06%. This contributed to the annual value of $12.1 million for FY2022, which is 10845062.04% up from last year.
- As of Q3 2023, ADC Therapeutics' Inventory stood at $22.7 million, which was up 4435.06% from $19.4 million recorded in Q2 2023.
- Over the past 5 years, ADC Therapeutics' Inventory peaked at $22.7 million during Q3 2023, and registered a low of $7718.0 during Q2 2021.
- Moreover, its 3-year median value for Inventory was $13.4 million (2022), whereas its average is $11.2 million.
- Per our database at Business Quant, ADC Therapeutics' Inventory surged by 19651588.41% in 2022 and then soared by 3261.43% in 2023.
- Over the past 3 years, ADC Therapeutics' Inventory (Quarter) stood at $8.7 million in 2021, then skyrocketed by 38.15% to $12.1 million in 2022, then skyrocketed by 88.25% to $22.7 million in 2023.
- Its Inventory was $22.7 million in Q3 2023, compared to $19.4 million in Q2 2023 and $18.2 million in Q1 2023.